Curbing Communication - Transanal Infiltration of Autologous Mesenchymal Stem Cells Facilitating Rectovesical Fistula Repair After Radical Prostatectomy.
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: inflammatory bowel diseases
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
In order to minimize the need for major surgery, autologous mesenchymal stem cells have been used to treat fistulas, especially in patients with inflammatory bowel diseases. We present a case of a patient with an iatrogenic rectovesical fistula that was successfully treated with transanal infiltration of mesenchymal stem cells around the rectal orifice of the fistula.
Treatment of acquired rectovesical or rectourethral fistula can be very challenging for surgeons.
APA
Eberspacher C, Lauro A, et al. (2025). Curbing Communication - Transanal Infiltration of Autologous Mesenchymal Stem Cells Facilitating Rectovesical Fistula Repair After Radical Prostatectomy.. Digestive diseases and sciences, 70(9), 3005-3009. https://doi.org/10.1007/s10620-025-09145-1
MLA
Eberspacher C, et al.. "Curbing Communication - Transanal Infiltration of Autologous Mesenchymal Stem Cells Facilitating Rectovesical Fistula Repair After Radical Prostatectomy.." Digestive diseases and sciences, vol. 70, no. 9, 2025, pp. 3005-3009.
PMID
40471497 ↗
Abstract 한글 요약
Treatment of acquired rectovesical or rectourethral fistula can be very challenging for surgeons. When a conservative approach fails, complex surgery is needed, with a substantial probability of complications and recurrences. In order to minimize the need for major surgery, autologous mesenchymal stem cells have been used to treat fistulas, especially in patients with inflammatory bowel diseases. We present a case of a patient with an iatrogenic rectovesical fistula that was successfully treated with transanal infiltration of mesenchymal stem cells around the rectal orifice of the fistula.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.